Haruo Naito: The Eisai Chairman and His 30-Year Pursuit of an Alzheimer's Drug
The journey of Haruo Naito, Chairman and CEO of Eisai, who persisted for more than three decades in Alzheimer's research despite repeated failures, ultimately producing Leqembi, a historic turning point in neurology.
Think & Rich